tiprankstipranks
Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI
US Market
BTAI
Bioxcel Therapeutics
RESEARCH TOOLSreports

Bioxcel Therapeutics (BTAI) Financial Statements

1,927 Followers

Bioxcel Therapeutics Financial Overview

Bioxcel Therapeutics's market cap is currently $29.78M. The company's EPS TTM is $-0.58; its P/E ratio is -0.39; Bioxcel Therapeutics is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 642.00K$ 2.27M$ 1.38M$ 375.00K$ 0.00
Gross Profit$ 178.00K$ 123.00K$ 120.00K$ 355.00K$ -297.00K
Operating Income$ -49.70M$ -67.25M$ -171.78M$ -159.65M$ -105.89M
EBITDA$ -49.41M$ -44.16M$ -165.42M$ -157.22M$ -107.00M
Net Income$ -69.90M$ -59.60M$ -179.05M$ -165.76M$ -106.93M
Balance Sheet
Cash & Short-Term Investments$ 28.41M$ 29.85M$ 65.22M$ 193.72M$ 232.97M
Total Assets$ 44.92M$ 38.34M$ 73.70M$ 205.85M$ 239.44M
Total Debt$ 109.59M$ 102.95M$ 101.38M$ 94.16M$ 1.40M
Net Debt$ 81.18M$ 73.09M$ 36.16M$ -99.57M$ -231.57M
Total Liabilities$ 140.38M$ 131.44M$ 130.21M$ 129.08M$ 17.77M
Stockholders' Equity$ -95.46M$ -93.10M$ -56.51M$ 76.78M$ 221.67M
Cash Flow
Free Cash Flow$ -57.62M$ -72.03M$ -155.03M$ -135.48M$ -82.60M
Operating Cash Flow$ -57.62M$ -72.03M$ -155.01M$ -135.34M$ -82.15M
Investing Cash Flow$ 0.00$ 0.00$ -20.00K$ -139.00K$ -445.00K
Financing Cash Flow$ 56.52M$ 36.66M$ 26.52M$ 96.24M$ 102.45M
Currency in USD

Bioxcel Therapeutics Earnings and Revenue History

Income Statement >

Bioxcel Therapeutics Debt to Assets

Balance Sheet >

Bioxcel Therapeutics Cash Flow

Cash Flow >

Bioxcel Therapeutics Forecast EPS vs Actual EPS

Earnings >